Core Insights - The 2026 X-Force Threat Intelligence Index by IBM reveals a significant increase in cyberattacks, particularly those exploiting public-facing applications, with a 44% rise attributed to missing authentication controls and AI-enabled vulnerability discovery [1][2] - Cybercriminals are leveraging AI to accelerate their attack strategies, leading to a more proactive need for businesses to adopt advanced threat detection and response mechanisms [2][7] Cybersecurity Trends - Infostealer malware exposed over 300,000 ChatGPT credentials in 2025, indicating that AI platforms now face similar credential risks as traditional enterprise SaaS solutions [3] - Compromised chatbot credentials pose unique risks, allowing attackers to manipulate outputs and exfiltrate sensitive data, highlighting the necessity for strong authentication and access controls [4] Ransomware Landscape - There was a 49% increase in active ransomware groups in 2025, driven by smaller operators utilizing leaked tools and AI to automate operations, complicating attribution [5][8] - The fragmentation of the ransomware ecosystem is evident, with publicly disclosed victim counts rising by approximately 12% [8] Supply Chain Vulnerabilities - A nearly 4X increase in large supply chain or third-party compromises since 2020 has been identified, primarily due to attackers exploiting trust relationships and CI/CD automation [6][8] - The pressure on software development pipelines is expected to grow as AI-powered coding tools introduce unvetted code into the ecosystem [6] Geographic and Sectoral Insights - Manufacturing remains the most targeted sector for the fifth consecutive year, accounting for 27.7% of incidents observed by X-Force, with data theft being the most common type of attack [10] - North America has emerged as the most attacked region, accounting for 29% of total cases, an increase from 24% in 2024 [10]

Core Viewpoint - Metalpha Technology Holding Limited, Exos Financial LLC, and BlockchainK2 Corp. have announced a joint venture aimed at providing compliant, institutional-grade digital asset solutions primarily for the US market, addressing the increasing demand for crypto-financial services [1] Group 1: Joint Venture Details - The joint venture will focus on three core areas: offering tailored OTC derivatives and hedging solutions, developing digital asset investment strategies, and creating securities-linked transactions for exposure to digital assets [1] - The collaboration combines Metalpha's expertise in cryptocurrency derivatives, Exos's regulated investment banking framework, and BlockchainK2's technology platforms for tokenization and fund distribution [1] Group 2: Company Profiles - Metalpha Technology Holding Limited is a leading provider of blockchain and trading technology solutions, focusing on digital asset management systems and liquidity solutions [1] - Exos Financial LLC is a B2B institutional finance platform that modernizes investment banking and wealth management services, operating regulated entities in the US [1] - BlockchainK2 Corp. is a holding company investing in blockchain technology solutions, with a majority interest in RealBlocks, which provides tokenized trading and fund distribution solutions [1]

Core Viewpoint - A securities fraud class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. for allegedly misleading investors regarding the efficacy of its drug setrusumab during the specified class period [2][4][7]. Group 1: Lawsuit Details - The lawsuit is filed on behalf of investors who purchased Ultragenyx common stock between August 3, 2023, and December 26, 2025 [2][7]. - The complaint alleges that Ultragenyx made false statements about the reliability of information regarding setrusumab's effects on Osteogenesis Imperfecta patients and downplayed risks associated with clinical trial results [4][7]. - Investors have until April 6, 2026, to file for lead plaintiff status in the lawsuit [2][9]. Group 2: Stock Performance - On December 29, 2025, Ultragenyx's stock price dropped over 42%, falling from $34.19 per share to $19.72 per share after the company announced that its Phase III studies did not achieve statistical significance [5][7]. Group 3: Investor Actions - Investors are encouraged to contact Kessler Topaz Meltzer & Check, LLP for a free case evaluation and to discuss their legal rights [3][10]. - Options for investors include filing to be a lead plaintiff by the deadline or choosing to remain an absent class member [9].

Kyndryl Holdings, Inc. (NYSE: KD) Securities Fraud Class Action Lawsuit Filed; April 13, 2026, Lead Plaintiff Deadline [Accessibility Statement] Skip NavigationDid you buy KD securities between August 7, 2024, and February 9, 2026?Affected Kyndryl Holdings, Inc. Investor Summary- Investor Action: Contact [Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)] for recovery options at no cost to investor- Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company's cash management pra ...

MEXICO CITY, Feb. 24, 2026 /PRNewswire/ -- Grupo Comercial Chedraui, S.A.B. de C.V. reports its 2025 fourth-quarter results. All figures are shown in nominal terms and reported under International Financial Reporting Standards (IFRS). 4Q'25 Highlights:  Same Store Sales (SSS) growth of 3.0% in Mexico.  Chedraui's Mexico SSS exceeded ANTAD's self-service SSS for the twenty-second consecutive quarter, this time by 164 basis points (bps).  Consolidated EBITDA margin 7.7% (excluding additional expenses 8.6%). ...

POM Investors with Large Losses Should Contact Robbins LLP for Information About the POMDoctor Ltd. Securities Class Action Lawsuit [Accessibility Statement] Skip NavigationSan Diego, Feb. 24, 2026 /PRNewswire/ -- [Robbins LLP] reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic dis ...

PSFE Investors with Large Losses Should Contact Robbins LLP for Information About the Paysafe Limited Securities Fraud Class Action Lawsuit [Accessibility Statement] Skip NavigationSAN DIEGO, Feb. 24, 2026 /PRNewswire/ -- [Robbins LLP] reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Paysafe Limited (NYSE: PSFE) securities between March 4, 2025 and November 12, 2025. Paysafe provides end-to-end payment solutions in the United States and intern ...

Robbins LLP Urges TCPC Investors With Larges Losses in BlackRock TCP Capital Corp. to Contact the Firm for Information About the Class Action Lawsuit[Accessibility Statement] [Skip Navigation]SAN DIEGO, Feb. 24, 2026 /PRNewswire/ -- [Robbins LLP] reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired BlackRock TCP Capital Corp. (NASDAQ: [TCPC]) securities between November 6, 2024 and January 23, 2026. BlackRock TCP is a business development company ...

Core Viewpoint - Wesco International, Inc. has announced the pricing of a private offering of senior notes totaling $1.5 billion, which will be used to redeem existing debt and repay borrowings under its credit facilities [1]. Group 1: Offering Details - The offering includes $650 million of 5.250% senior notes due 2031 and $850 million of 5.500% senior notes due 2034, with the latter amount increased from a previously announced $650 million [1]. - Both the 5-Year Notes and 8-Year Notes will be issued at a price of 100.000% of their aggregate principal amount [1]. - The settlement of the notes is scheduled for February 27, 2026, subject to customary closing conditions [1]. Group 2: Use of Proceeds - Wesco estimates that the net proceeds from the offering will be approximately $1.48 billion after deducting discounts and estimated offering expenses [1]. - The proceeds will be used to redeem all outstanding 7.250% senior notes due 2028 and to repay a portion of the outstanding amount under the asset-based revolving credit facility [1]. - Prior to redeeming the 2028 notes, the company plans to temporarily repay a portion of borrowings under its accounts receivable securitization facility and the ABL Facility [1]. Group 3: Company Overview - Wesco International is a leading provider of business-to-business distribution, logistics services, and supply chain solutions, with approximately $24 billion in annual sales in 2025 [1]. - The company operates over 700 sites in approximately 50 countries, providing a local presence and a global network for its customers [1]. - Wesco employs around 21,000 people and partners with premier suppliers to serve thousands of customers worldwide [1].

monoclonal antibodies. In addition, CD73 activity has been shown to promote angiogenesis, including through upregulation of VEGF signaling, and may contribute to the development of resistance to anti-VEGF therapies. Given the broad relevance of immune suppression, angiogenesis and adenosine signaling across solid tumors, this combination strategy has the potential to be applicable across multiple tumor types. Taken together, these observations suggest that combining CD73 blockade with PD-1/VEGF-directed app ...